Vaccine failed in front of new variant ‘Omicron’ of Corona? Pfizer, BioNTech made a big statement

At present, there is an atmosphere of concern around the world about the new variant of Corona ‘Omicron’. Along with this, there is also a discussion on whether the current vaccine of Corona Virus will work against this new variant or not. Now Pfizer and BioNtech have issued a statement in this regard. The statement said that he is not sure whether his vaccine will prove effective against the new COVID-19 variant ‘Omicron’.

However, according to the Sputnik report, Pfizer and BioNTech have promised to develop a new vaccine against the new variant in about 100 days. The World Health Organization (WHO) has announced that it has identified a new strain of corona, B.1.1.1.529, which was first found in southern Africa. The WHO has named this variant ‘Omicron’, which is a Greek word.

Vaccine to be made in 100 days: Pfizer and BioNtech
The companies said in the statement, “Pfizer and BioNTech expect to be able to develop and produce a vaccine against the new variants in approximately 100 days, subject to regulatory approval.” According to the report by Sputnik, Pfizer and BioNTech said they expect more data on ‘Omicron’ within the next two weeks.

Pfizer and BioNTech said that it has been seen that this variant is quite different from the earlier ones. The pharmaceutical companies underlined that they started working on adapting their vaccines to new potential variants months ago.

Many countries imposed travel restrictions on South Africa
This new variant of Corona was first found in South Africa, which has raised the concerns of the world. Many countries have imposed travel restrictions to South Africa to avoid this. America and Canada are also included in such countries. Apart from these, many countries have also done this.